Document is current
Any future updates will be listed below
-
Authors
Watterson, Taylor L.
Stone, Jamie A.
Gilson, Aaron
Brown, Roger
Xiong, Ka Z.
Schiefelbein, Anthony
Ramly, Edmond
Kleinschmidt, Peter
Semanik, Michael
Craddock, Lauren
Pitts, Samantha I.
Woodroof, Taylor
Chui, Michelle A.
-
Funding
Funding for this research was provided by:
National Council for Prescription Drug Programs Foundation
Gordon and Betty Moore Foundation (GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990, GBMF6990)
Agency for Healthcare Research and Quality (R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793, R21HS025793)
Clinical and Translational Science Award (UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373)
University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education
- License Information
-
More Information
Article History
Received: 4 May 2021
Accepted: 8 February 2022
First Online: 25 February 2022
Declarations
:
: This study was approved by the University of Wisconsin-Madison Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.
